DIGITALIZATION OF PERSONALISED HEALTH RISK MANAGEMENT
Launched by SLOVAK ACADEMY OF SCIENCES · May 17, 2025
Trial Information
Current as of July 27, 2025
Recruiting
Keywords
ClinConnect Summary
The clinical trial titled "Digitalization of Personalised Health Risk Management" is focused on helping individuals who are pre-obese or obese learn healthier lifestyle choices through a digital health program. The goal is to create a personalized approach that uses technology, like smartphone apps and wearable devices, to support people in making lasting changes to their habits. By working with both researchers and businesses, this project aims to develop a program that is effective, easy to use, and accessible to many people.
To participate in this trial, you should be between the ages of 18 and 70 and have a body mass index (BMI) between 27 and 42, which indicates obesity. You need to be comfortable using a smartphone and wearable technology, and willing to change your lifestyle based on the program's guidance. However, if you have certain health conditions that might interfere with participating, are currently in another weight-loss program, or have a history of severe addictions, you may not be eligible. If you join, you can expect to engage with digital tools designed to help you achieve your health goals while receiving support for making meaningful changes in your life.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • obesity (BMI 27-42 kg/m²)
- • capacity and willingness to use smartphone
- • capacity and willingness to use wearables
- • readiness to change (validated questionaire)
- Exclusion Criteria:
- • diseases that prevent participation in the program, or insufficiently controlled diseases, or terminal-stage illnesses
- • excessive alcohol consumption or a history of other addictions
- • patients currently participating in a weight-loss program (commercial, medically supervised, or a research study)
- • patients using anti-obesity medications who are in the dosage adjustment phase within the last four weeks
- • patients who are not mentally, physically, or technologically capable of participating
- • patients who are unable to provide informed consent
- • patients not adhering to the study protocol
About Slovak Academy Of Sciences
The Slovak Academy of Sciences (SAS) is a prestigious research institution dedicated to advancing scientific knowledge and innovation in Slovakia and beyond. Comprising a network of specialized research institutes, SAS fosters interdisciplinary collaboration and conducts cutting-edge research across various fields, including natural sciences, social sciences, and humanities. As a clinical trial sponsor, SAS is committed to ensuring rigorous scientific standards and ethical practices in its research endeavors, aiming to contribute to the development of new therapies and medical advancements that address pressing health challenges. Through its extensive expertise and resources, the Slovak Academy of Sciences plays a pivotal role in enhancing the landscape of clinical research and improving health outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bratislava, , Slovakia
Patients applied
Trial Officials
Jozef Ukropec, PhD, DSc
Principal Investigator
Biomedical Research Center Slovak Acad Sci
Zuzana Košutzka, A/prof., PhD
Study Chair
University Hospital Bratislava and Faculty of Medicine Comenius University
Emília Sičáková - Beblavá, Prof. Ing. PhD
Study Director
University Hospital Bratislava and Faculty of Medicine Comenius University
Miroslav Beblavý, A/prof. PhD
Study Director
University Hospital Bratislava and Faculty of Medicine Comenius University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported